drugset / Trial / NCT03673618
Soluble Corn Fiber Supplementation for Asthma
Phase 2
Completed
20 enrolled
Phoenix Children's Hospital
Flinn Foundation · collabMayo Clinic · collabNorthern Arizona University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Studies of the importance of the human microbiome have demonstrated that microbial metabolites of fermentation of our dietary products (e.g. dietary fiber) have a multitude of health benefits. The investigators aim to determine whether supplementation of asthmatic children with soluble corn fiber alongside standard of care reduces airway inflammation driven by the gut microbial metabolites acetate, propionate, or butyrate (short chain fatty acids).
Timeline
- Start
- 2019-09-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Soluble Corn Fiber | Unknown | 12 g | — |